Barriers and Facilitators to PrEP Initiation and Adherence Among Transgender and Gender Non-Binary Individuals in Southern California

AIDS Educ Prev. 2020 Dec;32(6):472-485. doi: 10.1521/aeap.2020.32.6.472.

Abstract

While transgender and gender non-binary (trans/nb) individuals are disproportionately affected by HIV, pre-exposure prophylaxis (PrEP) uptake remains low in this underserved population. We conducted four focus groups with 37 trans/nb individuals in San Diego and Los Angeles to assess barriers and facilitators of PrEP usage. Transcripts were coded for qualitative themes. Although overall PrEP awareness was high, participants reported limited knowledge and misinformation about PrEP. Barriers to PrEP use included: structural access (e.g., discrimination from health care providers, lack of trans-inclusive services, financial barriers), mental health struggles limiting ability to access PrEP, and concerns about potential side effects, drug-drug interactions with hormone therapy, and lack of other STI protection. Facilitators of PrEP usage included: increased PrEP availability, prior experience taking daily medications, and motivation to have active and healthy lives without fear of contracting HIV. Addressing both structural and psychosocial/behavioral factors in trans-affirming health care environments is crucial to designing inclusive, effective PrEP interventions.

Keywords: HIV prevention; STDs/STIs; gender non-conforming; health care disparities; pre-exposure prophylaxis; qualitative.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / therapeutic use
  • Attitude of Health Personnel
  • Discrimination, Psychological
  • Female
  • Focus Groups
  • HIV Infections / prevention & control*
  • Health Knowledge, Attitudes, Practice
  • Health Services Accessibility*
  • Healthcare Disparities
  • Humans
  • Los Angeles
  • Male
  • Pre-Exposure Prophylaxis / methods*
  • Qualitative Research
  • Transgender Persons*
  • Vulnerable Populations

Substances

  • Anti-HIV Agents